ANF-Rho: A Dose-Ranging Phase I Study to Determine Safety, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

被引：0

作者：

Parmar, Deven V. ^{[1
]}

Byczkowski, Daniel ^{[1
]}

Jubin, Ronald G. ^{[1
]}

Abuchowski, Abraham ^{[1
]}

Buontempo, Peter ^{[1
]}

Gitlin, Gerry ^{[1
]}

Boro, Michelle ^{[1
]}

Misra, Hemant K. ^{[1
]}

机构：

[1] Prolong Pharmaceut, South Plainfield, NJ USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers [J].

Maria Rosario ;

Timothy Wyant ;

Timothy Leach ;

Serap Sankoh ;

Catherine Scholz ;

Asit Parikh ;

Irving Fox ;

Brian G. Feagan .

Clinical Drug Investigation, 2016, 36 :913-923

[42] Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers [J].

Family, Neiloufar ;

Maillet, Emeline L. ;

Williams, Luke T. J. ;

Krediet, Erwin ;

Carhart-Harris, Robin L. ;

Williams, Tim M. ;

Nichols, Charles D. ;

Goble, Daniel J. ;

Raz, Shlomi .

PSYCHOPHARMACOLOGY, 2020, 237 (03) :841-853

[43] A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers [J].

Printz, Marie A. ;

Dychter, Samuel S. ;

DeNoia, Emanuel P. ;

Harrigan, Rena ;

Sugarman, Barry J. ;

Zepeda, Monica ;

Souratha, Jennifer ;

Kang, David W. ;

Maneval, Daniel C. .

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 93

[44] A phase I single rising dose study to investigate the safety, tolerance and pharmacokinetics of SANORG 34006 in healthy young male volunteers [J].

Faaij, RA ;

Burggraaf, J ;

Schoemaker, RC ;

van Amsterdam, RGM ;

Cohen, AF .

THROMBOSIS AND HAEMOSTASIS, 1999, :853-853

[45] Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study [J].

Kubitza, Dagmar ;

Heckmann, Michael ;

Distler, Jana ;

Koechel, Annemone ;

Schwers, Stephan ;

Kanefendt, Friederike .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) :3447-3462

[46] A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects [J].

Sheng Feng ;

Ji Jiang ;

Pei Hu ;

Jian-yan Zhang ;

Tao Liu ;

Qian Zhao ;

Bi-lu Li .

Acta Pharmacologica Sinica, 2012, 33 :1353-1358

[47] A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects [J].

Feng, Sheng ;

Jiang, Ji ;

Hu, Pei ;

Zhang, Jian-yan ;

Liu, Tao ;

Zhao, Qian ;

Li, Bi-lu .

ACTA PHARMACOLOGICA SINICA, 2012, 33 (11) :1353-1358

[48] A single and multiple postprandial dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban in healthy Chinese volunteers [J].

Chen, Xia ;

Liu, Dongyang ;

Wu, Yiwen ;

Liu, Yang ;

Song, Hanlin ;

Jiang, Ji ;

Hu, Pei .

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (03) :256-263

[49] The Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Ebronucimab in Healthy Volunteers: Result From a Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study [J].

Chen, Rui ;

Tian, Zhuang ;

Tang, Xiange ;

Hu, Pei ;

Wang, Lvya ;

Xia, Yu ;

Li, Baiyong ;

Wang, Max ;

Ni, Xiang ;

Wang, Guoqin ;

Zhang, Shuyang .

CIRCULATION, 2022, 146

[50] The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose-escalation Phase I study [J].

Fan, Yuxin ;

Yuan, Jiandong ;

Dong, Lichun ;

Yu, Chongjing ;

Ding, Haifeng ;

Xie, Daosheng ;

Guan, Runfang ;

Li, Ruixia ;

Zou, Wenhong ;

Long, Shuxian ;

Chen, Jion ;

Huang, Yu ;

Yang, Mei ;

He, Jianchang ;

Wen, Weibo .

DIABETES OBESITY & METABOLISM, 2025, 27 (04) :2110-2119

← 1 2 3 4 5 →